Aristeia Capital LLC Clovis Oncology, Inc. Put Options Transaction History

Aristeia Capital LLC

  • $2.93 Billion
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.05 - $2.85 $341,250 - $926,250
325,000 New
325,000 $387,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Aristeia Capital LLC Portfolio

Follow Aristeia Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristeia Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristeia Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email